Blog

These 6 startups are graduating from the Science Center’s Digital Health Accelerator

October 13, 2016

When the University City Science Center put out a call for the second iteration of its Digital Health Accelerator (DHA) program, 69 startups signed up for a spot. Only six companies from that pool made the cut, and next week, you’ll have a chance to see what they were up to during the 12-month program […]

Read More

ROAR for Good, Dreamit, BioBots, RevZilla featured on CNBC

October 3, 2016

“Startups are thriving in the City of Brotherly Love.” The final segment in CNBC’s Nightly Business Report dedicated six minutes to recapping the hustlin’, bustlin’ Philly tech scene. First up in the dispatch from reporter Kate Rogers was ROAR for Good CEO Yasmine Mustafa, who spoke about the company’s flagship Athena product. Mustafa herself showcased […]

Read More

Monetate Announces the Launch of its Revolutionary Dynamic Testing Solution

September 30, 2016

Monetate, the leading personalization provider for brands worldwide, today announced the launch of its newest innovative marketing solution, Dynamic Testing. Today’s marketers face more competition than ever before. They’re struggling to cut through the noise and win on the most strategic battleground: the customer experience. To address this new reality, Monetate is launching a solution […]

Read More

Livegenic Announces Global Partnership With ClaimLogik

September 30, 2016

Livegenic, a global provider of cloud-based, real-time video solutions to property and casualty (P&C) insurance organizations, is pleased to announce a global partnership with Australian-based solutions provider, ClaimLogik. Livegenic’s suite of real-time video collaboration, field loss documentation, and customer self-service solutions are fully-integrated into the ClaimLogik claim fulfilment platform to help facilitate faster damage assessments, […]

Read More

FDA Approves Janssen Biotech’s Drug for Crohn’s Disease

September 30, 2016

The Food and Drug Administration approved expanding the label for Horsham-based Janssen Biotech’s Stelara product to include its use for the treating Crohn’s disease. Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that affects about 700,000 Americans. The FDA approval of Stelara specified its use in adults 18 or older with moderately […]

Read More

Previous Next